Risperidone long-acting injection and Huntington's disease: Case series with significant psychiatric and behavioural symptoms

International Clinical Psychopharmacology

Volumn 26, Issue 2, 2011, Pages 114-119

  Johnston, Timothy Graeme ^a  

^a Ailsa Hospital   (United Kingdom)

Author keywords

depot; Huntington's disease; noncompliance; risperidone

Indexed keywords

RISPERIDONE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; HUMAN; HUNTINGTON CHOREA; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BEHAVIORAL SYMPTOMS; COGNITION; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; HUNTINGTON DISEASE; INJECTIONS; MALE; MIDDLE AGED; MOTOR ACTIVITY; PATIENT COMPLIANCE; PSYCHOTIC DISORDERS; RISPERIDONE; YOUNG ADULT;

EID: 79951513261     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/YIC.0b013e3283407775     Document Type: Article

References (20)

1. Bonelli RM, Hofmann P (2007). A systematic review of the treatment studies in Huntington's disease since 1990. Exper Opin Pharmacother 8:141-153. (Pubitemid 46206617)
2. Duff K, Paulsen JS, Beglinder LJ, Largbehn DR, Stout JC (2007). Psychiatric symptoms in Huntington's disease before diagnosis in the predict-HD study. Biol Psychiatry 62:1341-1346. (Pubitemid 350180721)
3. Duff K, Beglinder LJ, O'Rourke ME, Nopoulos P, Paulsen HL, Paulsen JS (2008). Risperidone and the treatment of psychiatric, motor and cognitive symptoms in Huntington's disease. Ann Clin Psychiatry 20:1-3. (Pubitemid 351302395)
4. Ho A, Robins A, Barker R (2006). Huntington's disease patients have selective problems with insight. Mov Disord 21:385-389.
5. Hoth K, Paulsen J, Moser D, Tranel D, Clark L, Bechara A (2007). Patients with Huntington's disease have impaired awareness of cognitive, emotional and functional abilities. J Clin Exp Psychopathol 29:365-376. (Pubitemid 46763628)
6. Houthoofd M, Morrens B, Sabe BG (2008). Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder. Clin Ther 30:1565-1589.
7. Jauhar S, Ritchie S (2010). Psychiatric and behavioural manifestations of Huntington's disease. Adv Psychiatr Treat 16:168-173.
8. Julien C, Thompson JC, Wild S, Yardunian P, Snowdon JS, Turner G, Crauford D (2007). Psychiatric disorder in preclinical Huntington's disease. J Neurol Neurosurg Psychiatr 78:939-943. (Pubitemid 47310828)
9. Keith SJ (2008). Use of long-acting risperidone in psychiatric disorder. Expert Rev Neurother 9:9-31.
10. Kim SW, Shin IS, Kim JM, Lee YH, Yang SJ, Yoon JS (2009). Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia. Hum Psychopharmacol 24:565-573.
11. Leroi I, Micholan M (1998). Treatment of the psychiatric manifestations of Huntington's disease; a review of the literature. Can J Psychiatry 43:933-940. (Pubitemid 29173303)
12. Madhusoodanan S, Brenner R (1998). Use of risperidone in psychosis associated with Huntington's disease. Am J Geriatr Psychiatry 6:347-349. (Pubitemid 28460132)
13. Norvak MJ, Tabrizi SJ (2010). Clinical review: Huntington's disease. Br Med J 340:3109.
14. Parellada E, Kouniakis F, Siurkute A, Schreiner A, Don L (2010). Safety and efficacy of long-acting injectable risperidone in daily practice. Int Clin Psychopharm 25:149-154.
15. Philips W, Shannon K, Barker R (2008). The current clinical management of Huntington's disease. Mov Dis 23:1491-1504.
16. Rawlins M (2010). Huntington's disease out of the closet? Lancet 376: 1372-1373.
17. Robertson L, Quarrell O, Brewer H, Barker R, Squilieri F, Landwehrmeyer B (2009). Current Pharmacological Management in Juvenile Huntington's disease (Abstract). Clin Genet 76 (Suppl 1):72.
18. Soliman S, Haque S, George E (2007). Stalking and Huntington's disease: a neurobiological link? J Forensic Sci Soc 52:1202-1204. (Pubitemid 47339081)
19. Terrence CF (1976). Fluphenazine decanoate in the treatment of chorea: a double-blind Study. Curr Ther Res Clin Exp 20:177-183.
20. Van Vugt J, Siesling S, Vergeer M, van der Velde E, Roos R (1997). Clozapine versus placebo in Huntington's disease. J Neurol Neurosurg Psychiatr 63:35-39.